In summary, this is the first study to demonstrate that significant differences exist between MPO-ANCA and PR3-ANCA diseases regarding the changes in amounts and types of glycans on the Fc portion of total IgGs with disease activity. This evidence concerns the gene PRTN3 and glycogen storage disease VI.